Scholar Rock · 2 months ago
Director, National Accounts (Midwest)
Scholar Rock is a biopharmaceutical company focused on developing innovative therapies for serious diseases. The Director, National Accounts role is critical for launching apitegromab, aimed at treating Spinal Muscular Atrophy, by establishing relationships with key payers and ensuring appropriate coverage for the drug.
BiopharmaBiotechnologyMedicalTherapeutics
Responsibilities
Lead account planning, management, and engagement activities at assigned payers to achieve rapid and clinically appropriate access for patients. This includes establishing and further developing relationships with decision makers at key customers
Support development of apitegromab’s value proposition and other supporting materials, including any account-specific needs
Maintain a strong understanding of apitegromab Commercial objectives and how to help achieve these goals through assigned accounts
Work across teams to ensure patient access objectives are met, including pull-through
Ensure all programs are aligned to Scholar Rock values and remain compliant with regulations
Lead presence with target accounts at access-related meetings, events and congresses (e.g., AMCP, PCMA, Asembia, Medicaid meetings, etc.)
Collaborate with Insights and Analytics and Commercial Operations to derive account-level insights and actions; communicate access and coverage performance regularly to internal stakeholders
Proactively identify and execute against opportunities to improve patient access to care, within and outside of Value & Access
Be a content expert on relevant industry trends, market dynamics, policy and legislation and define implications and actions for Scholar Rock
Be a collaborative, strategic market access presence throughout the Scholar Rock organization
Qualification
Required
Bachelors degree or advanced degree
At least 10 years' experience in US Market Access with a deep understanding of evolving access, coverage, and reimbursement landscape
5 years+ National Account Experience with existing relationships with CVS/Zinc/Aetna
National Account contracting experience
Experience and relationships with national and key regional Commercial, Medicaid, MAC's and other Government payers
Proven track record of achieving rapid, broad, and clinically appropriate coverage for medical benefit and/or rare disease products at launch
Comprehensive understanding of payer decision making bodies and cycles, processes/procedures, and data and reporting
Preferred
National Account Experience with existing relationships with CVS/Zinc/Aetna
National Account contracting experience
Rare disease launch experience
Experience negotiating agreements with large healthcare systems
Pre-launch experience at a small, start-up biotechnology company
Company
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Funding
Current Stage
Public CompanyTotal Funding
$743MKey Investors
InvusFidelityARCH Venture Partners
2024-10-08Post Ipo Equity· $300M
2023-10-11Post Ipo Equity· $85M
2022-06-17Post Ipo Equity· $205M
Leadership Team
Jay Backstrom
Chief Executive Officer
Recent News
Business Wire
2026-01-12
Morningstar.com
2025-12-13
Company data provided by crunchbase